• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Gambro

Baxter subsidiary sues B. Braun over blood filtration system

January 18, 2018 By Sarah Faulkner

Baxter (NYSE:BAX) and its subsidiary Gambro filed a patent infringement lawsuit against B. Braun last week, claiming that the German medical device maker’s Omni blood purification system infringes on seven of the patents covering Baxter’s Prismaflex system. The devices are used to treat patients who have acute kidney injuries and need help filtering out the waste […]

Filed Under: Legal News, Wall Street Beat Tagged With: B. Braun, Baxter, Gambro

China halts anti-dumping probe into EU, Japan dialysis kit makers

December 17, 2014 By MassDevice Contributors Network

China halts anti-dumping probe into EU, Japan dialysis kit makers

Filed Under: Dialysis, News Well Tagged With: Baxter, Dialysis, Exports, Fresenius, Gambro, Nikkiso America, Nipro

NxStage, Gambro bury the hatchet, renew supply deal

January 7, 2014 By Brad Perriello Leave a Comment

NxStage, Gambro bury the hatchet, renew supply deal
YYmeta

Filed Under: Legal News, News Well Tagged With: Baxter, Dialysis, Distribution, Gambro, NxStage Medical Inc.

Baxter and Gambro seal the deal on $3.9B acquisition

September 9, 2013 By Arezu Sarvestani Leave a Comment

Baxter and Gambro officially seal the deal on $3.9B merger

Baxter (NYSE:BAX) announced late last week that it finally sealed the deal on its $3.9 billion acquisition of Swedish dialysis giant Gambro AB, closing the books on a deal months in the making.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Baxter, Deals Roundup, Dialysis, Gambro

Aussie regulators approve Baxter’s $4B Gambro merger

September 5, 2013 By Arezu Sarvestani Leave a Comment

Aussie regulators approve Baxter's $4B Gambro merger

Filed Under: Mergers & Acquisitions, News Well, Regulatory/Compliance Tagged With: Baxter, Dialysis, Gambro

Baxter appeases EU regulators in $4B Gambro buyout

August 22, 2013 By Sony Salzman Leave a Comment

Baxter appeases EU regulators, closes $4B Gambro buyout

After months of negotiations with EuroZone regulators, Baxter‘s (NYSE:BAX) nearly $4 billion buyout of Swedish dialysis maker Gambro AB can go forward now that Baxter agreed to sell off its renal replacement therapy division to ease anti-trust concerns.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Baxter, Dialysis, European Commission, Gambro, Renal

Sources say Baxter’s near an agreement with EU regulators in $4B Gambro merger

July 11, 2013 By Sony Salzman Leave a Comment

Baxter proposes fixes to EU’s antitrust concerns

Healthcare giant Baxter (NYSE:BAX) may be on the verge of closing its $4 billion buyout of Swedish dialysis devices maker Gambro AB after offering to divest some of its assets in order to appease European regulators, according to anonymous sources cited by Reuters.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Baxter, Dialysis, Gambro

Baxter aims to soothe E.U. antitrust concerns over $4B Gambro merger

July 5, 2013 By Sony Salzman Leave a Comment

Baxter proposes fixes to EU’s antitrust concerns

Baxter (NYSE:BAX) offered European regulators concessions to lessen antitrust concerns over the $4 billion (26.5 billion SEK) acquisition of Swedish dialysis giant Gambro.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Baxter, Dialysis, Gambro

Greatbatch raises 2013 guidance on restructuring efforts | Wall Street Beat

June 6, 2013 By Arezu Sarvestani Leave a Comment

MassDevice.com Wall Street Beat

Texas medical device maker Greatbatch (NYSE:GB) raised its 2013 per-share earnings guidance as it announced new efforts to reorganize some of its business practices and reduce costs as it shifts from a components and sub-assemblies company to a developer of full medical devices.

Filed Under: News Well, Wall Street Beat Tagged With: Baxter, Electrochem, Gambro, Imaging3, integer, Kinetic Concepts Inc., Layoffs, Neurometrix

Medtronic closes strategic investment in LifeTech | Wall Street Beat

January 30, 2013 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Medtronic (NYSE:MDT) said it’s closed a $66 million investment in Chinese medical device company LifeTech Scientific (HK:8122).

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Baxter, Gambro, LifeTech Scientific Corp., Mardil Medical, Minnesota, NASDAQ, Solta Medical Inc., Sound Surgical Technologies, Uroplasty Inc.

Rumors of Baxter’s $4B Gambro buyout prove true

December 4, 2012 By MassDevice staff Leave a Comment

mergers and acquisitions illustration

Rumors circulating late last month proved true with Baxter (NYSE:BAX) this week announced that it had signed a $4 billion (26.5 billion SEK) merger agreement with Swedish dialysis giant Gambro.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Baxter, Dialysis, Gambro

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy